Showing results (171-180 of 856) with videos related to
Sort By:
Pageof 86
Diabetes, Obesity & Metabolism|January 16, 2009
Effect of linkage status of affected sib-pairs on the search for novel type 1 diabetes susceptibility genes in the HLA complexG Morahan, M Mehta, E McKinnon, et al.AJNR. American Journal of Neuroradiology|July 22, 1998
Spontaneous regression of a tectal mass in neurofibromatosis 1G Kim, M Mehta, W Kucharczyk, et al.Journal of Clinical and Experimental Neuropsychology|May 5, 2024
An evaluation of the moderating effects of routine and busyness on the relationship between prospective memory and everyday functioning in older persons with HIV diseaseDhruvi M Mehta, Steven Paul Woods, Nneka AkpotaireJournal of Immunotherapy : Official Journal of the Society for Biological Therapy|October 1, 1991
Immunological effects of levamisole in vitroJ H Schiller, M Lindstrom, P L Witt, et al.Leukemia|May 1, 1991
Establishment and characterization of an Epstein-Barr virus spontaneously transformed lymphocytic cell line derived from a hairy cell leukemia patientJ H Schiller, G Bittner, L F Meisner, et al.American Journal of Medical Genetics|October 31, 2000
Long forms of the dopamine receptor (DRD4) gene VNTR are more prevalent in substance abusers: no interaction with functional alleles of the catechol-o-methyltransferase (COMT) geneD J Vandenbergh, L A Rodriguez, E Hivert, et al.British Journal of Cancer|August 15, 2013
Baseline tumour measurements predict survival in advanced non-small cell lung cancerD E Gerber, S E Dahlberg, A B Sandler, et al.Journal of Biological Response Modifiers|August 1, 1990
Effects of combinations of interferon-beta ser and interferon-gamma on interferon-inducible proteins and on the cell cycleJ H Schiller, M A Horisberger, G Bittner, et al.Cancer|March 10, 2001
Central venous device-related infection and thrombosis in patients treated with moderate dose continuous-infusion interleukin-2M E Eastman, M Khorsand, D G Maki, et al.Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|May 1, 1996
Anti-renal-cell carcinoma chimeric antibody G250 facilitates antibody-dependent cellular cytotoxicity with in vitro and in vivo interleukin-2-activated effectorsJ E Surfus, J A Hank, E Oosterwijk, et al.Pageof 86